1 citations,
January 2019 in “PubMed” A woman developed a hair disorder after a bone marrow transplant, which improved with treatment.
1 citations,
January 2019 in “PubMed” Baldness score can't be used to predict prostate size.
1 citations,
April 2018 in “PubMed” The medulla in Asian scalp hair has a tubular structure that allows ions and large molecules to flow through it.
1 citations,
January 2018 in “PubMed” Women with PCOS have a similar chance of getting pregnant using assisted reproductive treatment as those without PCOS.
1 citations,
August 2017 in “PubMed” All five hair fiber products improved appearance but didn't stick to completely bald areas.
1 citations,
July 2017 in “PubMed” Hair loss can have negative psychological effects and treating it needs teamwork, especially from skin doctors.
1 citations,
July 2017 in “PubMed” Two patients with Cronkhite-Canada syndrome achieved remission after treatment.
1 citations,
February 2017 in “PubMed” The supplement may help hair growth and is safe, but more research is needed.
1 citations,
September 2016 in “PubMed” Using finasteride 0.5% solution with laser therapy significantly reduces unwanted facial hair in women.
1 citations,
July 2016 in “PubMed” The study compared the efficacy and safety of once-daily 5% minoxidil topical foam (MTF) to twice-daily 2% minoxidil topical solution (MTS) in treating female pattern hair loss. In a randomized, phase III trial involving 322 women, the primary endpoint was the change in target area hair count (TAHC) at 24 weeks. Results showed that 5% MTF increased TAHC by 23.9 ± 2.1 hairs/cm², while 2% MTS increased TAHC by 24.2 ± 2.1 hairs/cm². The treatment difference was -0.3 hairs/cm², with a 95% confidence interval of -6.0 to 5.4, failing to meet the noninferiority criteria. Both treatments were well tolerated, but the noninferiority goal was not achieved.
1 citations,
July 2016 in “PubMed” The study was a Phase III, randomized, double-blind, vehicle-controlled trial conducted at 17 international sites to evaluate the efficacy and safety of 5% minoxidil topical foam (MTF) in 404 women with female pattern hair loss (FPHL). Participants used either 5% MTF or vehicle foam once daily for 24 weeks. Results showed that 5% MTF significantly increased hair regrowth by 10.9 hairs/cm² at 12 weeks and 9.1 hairs/cm² at 24 weeks compared to the vehicle (P<.0001). Both subject self-assessment and expert panel review confirmed improved scalp coverage. Additionally, total unit area density (TUAD) increased significantly with 5% MTF. The treatment was well tolerated with minimal side effects. The study concluded that 5% MTF was effective and safe for promoting hair regrowth in women with FPHL.
1 citations,
April 2016 in “PubMed” 1 citations,
January 2016 in “PubMed” Keratogrow®, a spray made from patients' own blood, was found to increase hair growth and density when used twice daily for three months.
1 citations,
July 2015 in “PubMed” Human hair's strength comes from a honeycomb-like structure and macrofibrils.
1 citations,
February 2014 in “PubMed” Androgenic alopecia (AA) in Indian women is rarely reported, with varying severity and patterns, and hair pull tests and trichograms help understand it better.
1 citations,
January 2014 in “PubMed” Hair loss in a child was an early sign of Crohn's disease.
1 citations,
September 2013 in “PubMed” 1 citations,
April 2013 in “PubMed” The document concludes that female pattern baldness involves hair thinning, is classified differently than in men, and is assessed using the Ludwig classification. It also explains the hair growth cycle stages.
1 citations,
April 2013 in “PubMed” 1 citations,
March 2013 in “PubMed” Glycylglycine makes hair softer by improving alignment and changing hair's internal properties.
1 citations,
March 2013 in “PubMed” The study found that it's hard to tell the difference between two types of hair loss, alopecia areata and telogen effluvium, by looking at symptoms and tissue samples.
1 citations,
January 2013 in “PubMed” This study compared the efficacy of topical minoxidil 5% and adenosine 0.75% on male androgenetic alopecia in 110 male patients. After excluding 16 patients due to allergic reactions or loss to follow-up, the remaining participants were divided into two groups: one receiving minoxidil and the other adenosine. After 3 and 6 months, the relative recovery rates were not significantly different between the groups, and no patients achieved complete recovery. However, patient satisfaction was significantly higher in the adenosine group due to faster prevention of hair loss and the appearance of new hair. The study concluded that while adenosine did not show statistical superiority over minoxidil in recovery rates, it resulted in higher patient satisfaction. Further studies with larger sample sizes or different dosages were recommended.
1 citations,
December 2012 in “PubMed” Permanent wave treatment with thioglycolic acid changes hair structure by altering disulfide bonds.
1 citations,
October 2011 in “PubMed” Teen hair loss is common, can be caused by genetics or health issues, and can be diagnosed and treated.
1 citations,
January 2009 in “PubMed” PCOS affects many women and can cause various health issues, with several treatments available.
1 citations,
July 2007 in “PubMed” Androgenic alopecia is male or female pattern baldness.
1 citations,
November 2005 in “PubMed” Itraconazole effectively treats scalp fungus, with continuous use more effective than pulse therapy.
1 citations,
July 2004 in “PubMed” The study found that higher levels of ET-1 and SCF in early-stage dermal papilla cells improve their ability to regenerate hair follicles.
1 citations,
September 2002 in “PubMed” Minoxidil helps stimulate hair growth and reduce hair loss in women with androgenic alopecia.
1 citations,
August 2002 in “PubMed”